Gomesin [PYA1E]

General Information


DRACP ID  DRACP04688

Peptide Name   Gomesin [PYA1E]

Sequence  ECRRLCYKQRCVTYCRGR

Sequence Length  18

UniProt ID  P82358 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  1KFP 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Amidation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C93H157N35O25S4

Absent amino acids  ADFHIMNPSW

Common amino acids  R

Mass  259713

Pl  9.51

Basic residues  6

Acidic residues  1

Hydrophobic residues  2

Net charge  5

Boman Index  -8033

Hydrophobicity  -106.11

Aliphatic Index  37.78

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  3230

Absorbance 280nm  190

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27859052

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 18957441

Title  Not available

Doi Not available

Year  Not available

Literature 3

Pubmed ID 10942757

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  4435

DBAASP ID  10905

DRACP is developed by Dr.Zheng's team.